HBIO

Harvard Bioscience Inc.

Price

$7.98

return (12m)

53.40%

p/e

-3.63

p/bv

5.09

DIVIDEND YIELD

0.00%

HBIO price

Harvard Bioscience

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

33.44%

3 months

35.71%

1 year

53.40%

2 years

-73.22%

5 years

-90.34%

10 years

-70.55%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HBIO

Valuation

P/E

-3.63

Sector -0.16

Industry 2.77

P/BV

5.09

Sector 1.93

Industry 2.37

P/Revenue (PSR)

0.43

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

0.49

Sector 0.91

Industry 1.07

P/Net Current Assets

-1.68

Sector -24.70

Industry -5.25

P/Working Capital

1.74

Sector -5.32

Industry 3.11

EPS

-2.08

Sector -0.79

Industry -0.61

BVPS

1.48

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

58.15%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

-0.27%

Sector -23.12%

Industry -27.36%

Net Profit Margins

-11.86%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.30

Sector 0.13

Industry 0.15

Profitability

ROE

-140.30%

Sector -31.93%

Industry -27.86%

ROA

-13.65%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.87

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

4.94

Sector -1.04

Industry -0.12

Gross Debt / Equity

4.94

Sector -0.72

Industry 0.10

Equity/Assets

0.10

Sector 0.43

Industry 0.45

Liabilities/Assets

0.90

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

-5.88%

Sector -

Industry -

5Y Earnings CAGR

104.65%

Sector -

Industry -

Fundamentals HBIO

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HBIO Harvard Bioscience Inc.	$7.98	49.41%	0.00%	-3.63	5.09	-140.30%	-11.86%
TMO Thermo Fisher Scientific Inc.	$618.91	27.34%	0.29%	33.36	4.42	13.26%	15.08%
DHR Danaher Corporation	$215.43	5.71%	0.67%	37.88	2.88	7.61%	15.95%
WAT Waters Corporation	$413.55	38.94%	0.00%	244.98	2.68	1.09%	3.58%
IQV IQVIA Holdings Inc.	$261.90	38.72%	0.00%	31.33	6.86	21.89%	8.12%
SHC Sotera Health Company	$19.32	17.09%	0.00%	33.54	8.24	24.56%	13.44%
CGEN Compugen Ltd.	$2.62	77.89%	0.00%	6.99	2.77	39.65%	47.54%
SYNH Syneos Health Inc.	$0.00	-	0.00%	62.97	1.28	2.04%	1.31%
LLY Eli Lilly and Compay	$1,169.97	61.21%	0.52%	41.58	-	-%	33.53%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
SNY Sanofi	$44.84	-7.34%	3.87%	7.43	1.37	18.43%	13.81%
NVS Novartis AG	$153.04	22.95%	1.96%	28.21	7.75	27.47%	26.57%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
GSK GlaxoSmithKline PLC	$50.24	31.67%	3.42%	15.92	4.50	28.24%	14.54%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
HCA HCA Healthcare Inc.	$419.06	4.14%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Harvard Bioscience

Harvard Bioscience Inc.

Average Investor10 user rating

4.0 (0 people)

United States

26 years

Founded: 2000

2000

Time since IPO - 26 years

505

Employees

Harvard Bioscience Inc. (United States) is listed on the Nasdaq and has a market capitalization of $37.75 million, with shareholders equity totaling $7.42 million.

The company employs approximately 505 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Harvard Bioscience Inc. reported $87.80 million in revenue, generating net income of $-10.41 million.

Key financial metrics include a P/E ratio of -3.63, a price-to-book (P/B) ratio of 5.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HBIO.

Market cap

$37.75 million

Net worth

$7.42 million

$7,420,000.00

Assets

$76.29 million

$76,290,000.00

Total Shares Outstanding

5.00 million

5,000,000

Average Daily Trading Volume

$17.03 Thousand

$17,030.66

Sector

Health

Industry

Life Science Tools and Services

HBIO

HBIO revenue and profits

Financial Results HBIO

DRAG THE FRAME TO SEE MORE DATA

HBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75